Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1990-11-01
1992-02-11
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424851, 514 2, 530399, A61K 3722, A61K 4505, A61K 3724
Patent
active
050874535
ABSTRACT:
A method for treating cachexia is provided, comprising the step of administering to a patient an amount of macrophage colony-stimulating factor (M-CSF) effective for said treatment.
REFERENCES:
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4847201 (1989-07-01), Kaswasaki et al.
patent: 4868119 (1989-09-01), Clark et al.
patent: 4879111 (1989-11-01), Chong
patent: 4879227 (1989-11-01), Clark et al.
patent: 4916118 (1990-04-01), Fidler et al.
patent: 4921837 (1990-05-01), Donahue
Karbassi et al., J. Immunol. 139, 417-421 (1987).
Beutler et al., "The Common Mediator of Shock, Cachexia, and Tumor Necrosis", Advances in Immunology, vol. 42:213-231 (1988).
Brenner et al., "Tumor Necrosis Factor-.alpha. Inhibits Albumin Gene Expression in a Murine Model of Cachexia", Journal of Clinical Investigation, vol. 85:248-255 (Jan. 1990).
Fleit et al., "Interferon Induction in Marrow-Derived Macrophages: Regulation by L Cell Conditioned Medium", Journal of Cellular Physiology, vol. 108:347-352 (1981).
Sampson-Johannes et al., "Enhancement of Human Monocyte Tumoricidal Activity by Recombinant M-CSF", Journal of Immunology, vol. 141(10):3680-3686 (Nov. 15, 1988).
Karbassi et al., "Enhanced Killing of Candida albicans by Murine Macrophages Treated with Macrophage Colony-Stimulating Factor: Evidence for Augmented Expression of Mannose Receptors", Journal of Immunology, vol. 139(2):417-421 (Jul. 15, 1987).
Lawson et al., "Metabolic Approaches to Cancer Cachexia", Ann. Rev. Nutr., vol. 2:277-301 (1982).
Lee et al., "CSF-1-Induced Resistance to Viral Infection in Murine Macrophages", Journal of Immunology, vol. 138:3019-3022 (1987).
Mahony et al., "Comparison of Weight Loss Induced by Recombinant Tumor Necrosis Factor with that Produced by a Cachexia-Inducing Tumor", Br. J. Cancer, vol. 57:385-389 (1988).
Michie et al., "Tumor Necrosis Factor and Endotoxin Induce Similar Metabolic Responses in Human Beings", Surgery, vol. 104(2):280-286 (Aug. 1988).
Mufson et al., "Macrophage Colony-Stimulating Factor Enhances Monocyte and Macrophage Antibody-Dependent Cell-Mediated Cytotoxicity", Cellular Immunology, vol. 119:182-192 (1989).
Ralph, "Activating Factors for Nonspecific and Antibody-Dependent Cytotoxicity by Human and Murine Mononuclear Phagocytes", Lymphokine Research, vol. 3(4):153-161 (1984).
Ralph et al., "Molecular Biological Properties of Human Macrophage Growth Factor, CSF-1", Cold Spring Harbor Symposia on Quantitative Biology, vol. LI:679-683 (1986).
Ralph et al., "Molecular Biology, Cell Biology and Clinical Future of Myeloid Growth Factors", The Year in Immunology, vol. 5:103-125 (1989).
Retzinger et al., "The Role of Surface in the Biological Activities of Trehalose 6,6'-Dimycolate", J. Biol. Chem., vol. 256:8208-8216 (Aug. 10, 1981).
Sherry et al., "Cachectin/Tumor Necrosis Factor Exerts Endocrine, Paracrine, and Autocrine Control of Inflammatory Responses", Journal of Cell Biology, vol. 107:1269-1277 (Oct. 1988).
Sherry et al., "Anticachectin/Tumor Necrosis Factor-.alpha. Antibodies Attenuate Development of Cachexia in Tumor Models", FASEB Journal, vol. 3:1956-1962 (Jun. 1989).
Silva et al., "Mouse Cachexia Induced by Trehalose Dimycloate from Nocardia Asteroides", Journal of General Microbiology, vol. 134:1629-1633 (1988).
Silva et al., "Tumor Necrosis Factor (Cachectin) Mediates Induction of Cachexia by Cord Factor from Mycobacteria", Infection and Immunity, vol. 56(12):3067-3071 (Dec. 1988).
Suzu et al., "Enhancing Effect of Human Monocytic Colony-Stimulating Factor on Monocyte Tumoricidal Activity", Cancer Research, vol. 49:5913-5917 (Nov. 1, 1989).
Theologides, "Cancer Cachexia", American Cancer Society, vol. 43(5):2004-2012 (May 1979 Supp.).
Tisdale et al., "Inhibition of Weight Loss by .omega.-3 Fatty Acids in an Experimental Cachexia Model", Cancer Research, vol. 50:5022-5026 (Aug. 15, 1990).
Tracey et al., "Cachectin/TNF Mediates the Pathophysiological Effects of Bacterial Endotoxin/Lipopolysaccharide (LPS)", Prog. Clin. Biol. Research, vol. 242:77-88 (1988).
Tracey et al., "Cachectin/Tumor Necrosis Factor Induces Cachexia, Anemia, and Inflammation", J. Exp. Med., vol. 167:1211-1227 (Mar. 1988).
Van Eys, "Nutrition and Cancer: Physiological Interrelationships", Ann. Rev. Nutr., vol. 5:435-461 (1985).
Vogel et al., "Recombinant Interleukin-1.alpha. and Recombinant Tumor Necrosis FActor .alpha. Synergize In Vivo to Induce Early Endotoxin Tolerance and Associated Hematopoietic Changes", Infection and Immunity, vol. 56(10):2650-2657 (Oct. 1988).
Warren et al., "Macrophage Growth Factor CSF-1 Stimulates Human Monocyte Production of Interferon, Tumor Necrosis Factor, and Colony Stimulating Activity", Journal of Immunology, vol. 137(7):2281-2285 (Oct. 1, 1988).
Wing et al., "Changes in Serum Colony-Stimulating Factor and Monocytic Progenitor Cells During Listeria monocytogenes Infection in Mice", Infection and Immunity, vol. 45(1):180-184 (Jul. 1984).
Hughes et al., "Modulation of Tumor Necrosis Factor Activities by a Potential Anticachexia Compound, Hydrazine Sulfate", Int. J. Immunopharmacol., vol. 11(5):501-507 (1989) (abstract only).
Aukerman et al., "Preclinical Pharmacology of Recombinant Human M-CSF", J. Leukocyte Biology, p. 102, No. 292 (Supplement 1990) (abstract).
Lathey et al., "Weight Loss in Obese Mice Persistently Infected with Lymphocytic Choriomeningitis Virus is Not Associated with Elevated Tumor Necrosis Factor/Cachectic Activity in Peritoneal Macrophages", Am. J. Pathol., 132(3):586-592 (Sep. 1988).
Sabatini et al., "Stimulation of Tumor Necrosis Factor Release from Monocytic Cells by the A375 Human Melanoma via Granulocyte-Macrophage Colony-Stimulating Factor", Cancer Res., vol. 50(9):2673-2678 (May 1, 1990) (abstract only).
Kishore G. S.
Otsuka Pharmaceutical Co. Ltd.
Page Thurman K.
LandOfFree
Method for the treatment of bacterial caused weight loss and/or does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of bacterial caused weight loss and/or , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of bacterial caused weight loss and/or will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-780806